Anatara Lifesciences Ltd [ASX:ANR] share price and news 2022

Company Description

Anatara Lifesciences Ltd (ANR) is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. They are currently focused on building a pipeline of evidence-based, over-the-counter gastrointestinal health products, through in-house development and in-licencing and distribution opportunities. Their lead products are Detach for animals and Gastrointestinal Reprogramming dietary supplement for humans.

Anatara Lifesciences Ltd belongs to Health Care sector and under industry of Biotechnology. You can get more information about this company via their website:

This a small cap company with market cap of 11 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 2.97 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how anr dividend grows in the recent years.

No data